Carl Majeski
Account Manager-hematology @Beigene
Signup · Get unlimited contacts
WORK HISTORY
Account Manager-hematology @Beigene
PA, US
Responsible for the promotion of Brukinsa (zanubrutinib) in Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Waldenstroms Macroglobulinemia, Marginal Zone Lymphoma and Follicular Lymphoma. • Successfully launched Brukinsa to market in 2019 when it received its first FDA approved indication in Mantle Cell Lymphoma• Successfully launched Brukinsa in 4 subsequent new indications. • Winner of 2024 Summit Club contest by successfully promoting Brukinsa in 5 separate disease states. I was able to finish 2024 ranked #8 in the company out of 84 representatives.
EDUCATION
Temple University
Bachelor of Business Administration (B.B.A.), Marketing/Risk Management Insurance
SKILLS
ABOUT CARL MAJESKI
34 years of successful pharmaceutical experience, 26 of those 34 years in a complex oncology arena gaining me a wide range of sales and reimbursement experience including:• Back to back Summit Club winner with BeOne Medicines (2024 and 2025)• 4 time Diamond Club winner with Celgene.(2005, 2008, 2011, 2016)• Presidents Circle Winner with Berlex (2002)• Currently responsible for the promotion and sale of Brukinsa (zanubrutinib) in Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Waldenstom’s, Marginal Zone Lymphoma and Folicular Lymphoma. • Successfully launched Brukinsa to market in initial MCL indication then in four additional indications in the next 4 years. • Responsible for the promotion and sale of Revlimid in combination with Rituxan in Folicular and Marginal Zone Lymphoma, Revlimid in MDS and Multiple Myeloma and Abraxane in Metastatic Breast Cancer, Non-Small Cell Lung Cancer and Metastatic Pancreatic Cancer. Previously promoted Thalidomide and Vidaza in Myelodysplastic Syndrome (MDS) and Multiple Myeloma.• Collaborating with cross functional partners to help patients obtain access to appropriate products by overcoming reimbursement and payer coverage obstacles as well as financial hardship obstacles. • Experience in contracting with customers both directly and in collaboration with cross functional partners.• Extensive experience with Celgene’s Risk Evaluation and Mitigation Strategy (REMS) program. • Experience with injectable, infusion, oral and buy and bill drugs in the hospital and clinic setting. • ICD-9 and ICD-10 coding• Specialty Pharmacy• Medicare Part B and DCareer Achievements:• Promoted to Executive Hematology Oncology Consultant (June 2018)• 6 time performance contest winner in my career as an oncology representative. • Won Summit Club Contest with BeiGene (2024)• Won 4 Diamond Club Contests with Celgene.• Winner of 2016 Diamond Club Contest selling Abraxane with the Oncology Division. Finished 2016 ranked #5 in the country out of 99 representatives. • Winner of 2011 Diamond Club Contest in my first year after being transferred to new Solid Tumor Division. • Winner of 2008 Diamond Club Contest in my first year as an MDS Specialty Representative.• Winner of 2005 Diamond Club Contest by successfully launching Revlimid in MDS and was ranked #2 in the nation for launch period.• Promoted to Senior Hematology Oncology Consultant in 2012.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.